论文信息 - Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome. - 字舞流文

Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome.

J. Orange | Ji Young Kim | S. Jyonouchi | N. Kobrinsky | S. Roy-Ghanta | Lavesh A Gwalani | Maria Ahmad | C. Moertel | Brenda Gwafila | Cecil Holbert